News
26
2021-05
BrosMed received CE mark approval for Pronavi™ Microcatheter
Sittard, Netherlands [May 26, 2021] –BrosMed received CE Mark approval in the European Union for its Pronavi™ Microcatheter. This device is indicated for use in both coronary and peripheral interventions.
2021-05-26
24
2021-05
Guangdong ,China [May 24 , 2021] – Brosmed Co., Ltd. has received a 510(k) clearance from the U.S. Food & Drug Administration for its Artimes™ Pro PTCA balloon catheter.
2021-05-24
11
2021-05
Optimize Percutaneous Coronary Intervention with a Scoring Balloon Webinar
Guangdong [May 11 , 2021] – Brosmed Medical Ltd. hosted its first global webinar: Optimize Percutaneous Coronary Intervention with a Scoring Balloon on April 27th 2021. This webinar was hosted by Prof. Stephane Carlier from Belgium together with Dr. Bernardo Cortese from Italy and Prof. Jo Dens from Hart Center Genk in Belgium.
2021-05-11
07
2021-04
Artimes™ Pro Clinical Trial Completed Successfully in the U.S.
A clinical trial of Artimes™ Pro, a rapid exchange coronary balloon dilatation catheter manufactured by BrosMed Medical, has been successfully completed in the United States. The diameters of the balloon dilatation catheters are 1.0 mm and 1.25 mm. The crossing profile of 1.0mm balloon is ultra-small of 0.0218’’, which is suitable for CTO lesions.
2021-04-07
05
2020-06
BrosMed obtained CE certificate for Interventional Accessories
May 27th, 2020—BrosMed Medical Co., Ltd. announced that the CE and ISO certificates for 10 interventional accessories have been obtained at the same time!This is the 4th CE certificate after Alveo High pressure Balloon Catheter, Wedge NC scoring balloon catheter and the Tri-Wedge PTA Scoring Balloon Catheter. This shows Brosmed achieves another milestone in interventional area.
2020-06-05
19
2020-02
February 19th, 2020—BrosMed Medical Co., Ltd. announced CE Mark and launched its Wedge NC Scoring Balloon Catheter and Alveo HP Balloon Catheter . Wedge NC and Alveo HP are for the treatment of Percutaneous Transluminal Coronary Angioplasty (PTCA) by improving myocardial blood flow in the localized stenotic lesion of the coronary arteries.
2020-02-19
19
2020-01
February 19th, 2020—BrosMed Medical Co., Ltd. announced CE Mark and launched its Tri-Wedge PTA Balloon Catheter. Tri-Wedge is a Percutaneous Transluminal Angioplasty (PTA) Scoring Balloon Dilatation Catheter, which ideal for Arteriovenous Fistula (AV) Shunt Scoring.
2020-01-19
14
2018-12
Mr. Roy Noda — Asia-Pacific President of Cardinal Health Visits BrosMed Medical
December 11st, 2018, Mr. Roy Noda, Asia-Pacific President of Cardinal Health (www.cardinalhealth.com), Ms. Jessie, General Manager in China and their team visited BrosMed Medical.
2018-12-14